Paradigms for dual antiplatelet therapy after PCI challenged by PARIS trial




New study results show among patients undergoing percutaneous coronary intervention (PCI) with stents, the risk of cardiovascular complications after stopping dual antiplatelet therapy (DAPT) is highly variable depending on the context, and some patients experience no complications at all.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/-...

Lunes, 2 de Septiembre 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección